Patent ID: 9327026
Filing Date: 2016-05-03
CPC Classification: A61K,A61P

Claim Text:
1. A method of preventing or treating breast cancer expressing human α-lactalbumin, human αS1 casein, human β-casein or human κ-casein in a non-lactating human female of a non-child bearing age in whom the genes encoding human α-lactalbumin, human αS1 casein, human β-casein and human κ-casein are not expressed by normal breast tissue, said method comprising administering to said non-lactating human female a multivalent antigenic composition comprising: (i) human α-lactalbumin or a polypeptide comprising a 15 amino acid fragment thereof; (ii) human αS1 casein or a polypeptide comprising a 15 amino acid fragment thereof; (iii) human β-casein or a polypeptide comprising a 15 amino acid fragment thereof; and (iv) of human κ-casein or a polypeptide comprising a 15 amino acid fragment thereof, wherein the multivalent antigenic composition is administered in an amount effective to elicit a T-cell-mediated anti-tumor immune response against said breast cancer.